Update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc.
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lupin's Dutch wholly-owned subsidiary Nanomi B.V. is acquiring minority shareholding in Multicare Pharmaceuticals Philippines, Inc. from existing shareholders. The deal, originally expected to close by end of May 2026, has been delayed and is now anticipated to complete in July 2026. The transaction remains subject to certain closing conditions. This acquisition increases Lupin's control over its subsidiary, consistent with the company's original April 2026 intimation.
The delay of roughly six weeks should have minimal direct impact on Lupin's stock, as the deal is still on track pending closing conditions. Shareholders can expect finalisation by mid-2026.